key: cord-0958951-1pxu0lmp
authors: Pluymaekers, Nikki A.H.A.; Hermans, Astrid N.L.; van der Velden, Rachel M.J.; den Uijl, Dennis W.; Vorstermans, Bianca; Buskes, Saskia; Hendriks, Jeroen M.; Vernooy, Kevin; Crijns, Harry J.G.M.; Linz, Dominik
title: On-demand app-based rate and rhythm monitoring to manage atrial fibrillation through tele-consultations during COVID-19
date: 2020-05-08
journal: Int J Cardiol Heart Vasc
DOI: 10.1016/j.ijcha.2020.100533
sha: e4c7e6b6626ffef085970e926938198eabf3d5e6
doc_id: 958951
cord_uid: 1pxu0lmp

nan

During the coronavirus 2019 (COVID-19) pandemic, traditional face-to-face outpatient consultations in atrial fibrillation (AF) clinics were transformed into tele-consultations.

Herein, we describe how we implemented a remote on-demand mobile health (mHealth) infrastructure, which was based on a mobile phone app using photoplethysmography (PPG) technology allowing rate and rhythm monitoring through tele-consultations (summarized in the figure).

We asked our secretaries to call all patients 5-7 days before scheduled tele-consultations.

The patients were instructed to download the FibriCheck mobile phone app (www.fibricheck.com). This app is CE marked, connected to a secured and certified cloud and validated to detect AF via PPG signals and to provides rate measures during sinus rhythm and AF 1,2 . A manual outlining the download and registration process of the app was sent to the patient via email. After download and registration, patients activated a 7-day ondemand prescription by scanning a QR code which linked the app to a cloud accessible by the treating physician. The patients were instructed to use the app three times per day and in the case of symptoms.

Between March 25 and April 1 2020, 38 patients with a planned tele-consultation for AF management in the Maastricht University Medical Centre+ were contacted (age 66 years (range 40-78), 57% female). Thirty (79%) patients agreed to use the app, six (16%) patients did not have access to a mobile phone or tablet and were therefore excluded, two (1%) patients refused to use the app. During the tele-consultation at 5-7 days after the initial patient contact, the patients´ feedback was overwhelmingly positive. In total, 651 measurements were recorded and the quality of just 64 (10%) measurements was too low for automatic analysis. The FibriCheck algorithm defined 398 (61%) measurements as normal sinus rhythm, 143 (22%) as AF and 46 (7%) as sinus rhythm with extrasystoles. The average number of measurements per participant was 22. After each measurement, symptoms were assessed by the app: 77% of measurements were asymptomatic, dyspnea was present in 5%, palpitations in 2%, chest pain in 1% and in 15% other symptoms were reported. FibriCheck information was used for management of rate and rhythm control medication in patients planned for AF outpatient clinic or follow-up after AF ablation.

During COVID-19, we implemented an on-demand app-based rate and rhythm monitoring to manage AF patients through tele-consultations in our AF-clinic, with fundamental key elements included. A case coordinator, in our team the secretary, is the main contact person for the patients explaining the app or in case of issues 3 This application of mHealth is new compared to previous settings. The goal was to monitor rate and rhythm remotely just around tele-consultations to allow a better assessment of the disease state of the patient and to support in treatment decisions. This on-demand approach was regulated by a prescription to use the app for a limited predefined time period, which avoids unnecessary data-load and additional follow-up patients-contacts.

The relatively low cost, convenience, and broad accessibility of the mobile phone app used in this approach allows a fast and broad implementation of the herein described mHealth infrastructure during the COVID-19 pandemic. No hardware is required which has several hygienic and logistical advantages. A potential disadvantage is that no electrocardiogram is provided.

In conclusion, it is feasible to implement a novel app-based on-demand rhythm and rate monitoring infrastructure to efficiently provide tele-consultations in an AF population.

Currently, we make this infrastructure widely available in numerous European centers within the TeleCheck-AF project to manage and improve AF patient care during the COVID-

On-demand app-based rate and rhythm monitoring to manage atrial fibrillation patients through tele-consultation.

Atrial fibrillation screening with photo-plethysmography through a smartphone camera

Mobile Phone-Based Use of the Photoplethysmography Technique to Detect Atrial Fibrillation in Primary Care: Diagnostic Accuracy Study of the FibriCheck App

The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation

Patient-Centered Educational Resources for Atrial Fibrillation